Revenue: The sum of all revenue fields included for a company's operating activities.
Pliant Therapeutics, Inc. (PLRX) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-210.30M |
|
-- |
|
-- |
|
$228.37M |
|
$-228.37M |
|
$18.06M |
|
$-210.30M |
|
$-210.30M |
|
$-210.30M |
|
$-210.30M |
|
$-210.30M |
|
$-210.30M |
|
$-228.37M |
|
$-223.73M |
|
60.54M |
|
60.54M |
|
$-3.47 |
|
$-3.47 |
|
| Balance Sheet Financials | |
$362.26M |
|
$5.53M |
|
$34.69M |
|
$396.95M |
|
$33.22M |
|
$30.21M |
|
$59.65M |
|
$92.87M |
|
$304.08M |
|
$304.08M |
|
$304.08M |
|
60.86M |
|
| Cash Flow Statement Financials | |
$-155.50M |
|
$140.34M |
|
$23.12M |
|
$64.72M |
|
$72.67M |
|
$7.95M |
|
$37.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.91 |
|
-- |
|
-- |
|
0.09 |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-159.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-69.16% |
|
-69.16% |
|
-52.98% |
|
-62.91% |
|
$5.00 |
|
$-2.63 |
|
$-2.57 |
|